Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Qualigen Therapeutics Inc (QLGN)
NASDAQ:QLGN
Holding QLGN?
Track your performance easily
QLGN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.34 - $30.50
Previous Close$3.87
Volume108.60K
Average Volume (3M)89.80K
Market Cap
$2.85M
Enterprise Value$2.46M
Total Cash (Recent Filing)$388.15K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.58
Next Earnings
Aug 13, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-55.30
Shares Outstanding736,431
10 Day Avg. Volume44,061
30 Day Avg. Volume89,801
Standard Deviation0.36
R-Squared0.01
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)-1.51
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.34
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Qualigen Therapeutics News
PremiumCompany Announcements
Qualigen Therapeutics Appoints Graydon Bensler to Board
PremiumCompany Announcements
Qualigen Therapeutics Announces 1-for-50 Reverse Stock Split
PremiumCompany Announcements
Qualigen Therapeutics Board Experiences Key ChangesOwnership Overview
―
Insiders
3.97% Mutual Funds
― Other Institutional Investors
96.03% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
QLGN FAQ
What was Qualigen Therapeutics Inc’s price range in the past 12 months?
Qualigen Therapeutics Inc lowest stock price was $3.33 and its highest was $30.50 in the past 12 months.
What is Qualigen Therapeutics Inc’s market cap?
Currently, no data Available
When is Qualigen Therapeutics Inc’s upcoming earnings report date?
Qualigen Therapeutics Inc’s upcoming earnings report date is Aug 13, 2024 which is 131 days ago.
How were Qualigen Therapeutics Inc’s earnings last quarter?
Currently, no data Available
Is Qualigen Therapeutics Inc overvalued?
According to Wall Street analysts Qualigen Therapeutics Inc’s price is currently Overvalued.
Does Qualigen Therapeutics Inc pay dividends?
Qualigen Therapeutics Inc does not currently pay dividends.
What is Qualigen Therapeutics Inc’s EPS estimate?
Qualigen Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Qualigen Therapeutics Inc have?
Qualigen Therapeutics Inc has 736,431 shares outstanding.
What happened to Qualigen Therapeutics Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Qualigen Therapeutics Inc?
Currently, no hedge funds are holding shares in QLGN
---
Qualigen Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-88.09%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-46.41%
Trailing 12-Months
Company Description
Qualigen Therapeutics Inc
Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat digestive disorders and gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. The company was founded by Andrew J. Ritter and Ira E. Ritter on March 29, 2004 and is headquartered in Los Angeles, CA.
---
Technical Analysis
---